Acute myelopathy during chemotherapy for childhood acute lymphoblastic leukemia

Pediatr Int. 2021 Jun;63(6):736-738. doi: 10.1111/ped.14500. Epub 2021 Apr 24.

Authors

Kazuki Matsumoto¹, Tomoya Takeuchi², Hirotoshi Sakaguchi¹, Nao Yoshida¹, Asahito Hama¹

Affiliations

¹ Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
² Department of Neurology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

PMID: 33894042
DOI: 10.1111/ped.14500

No abstract available

Keywords: acute lymphoblastic leukemia; acute myelopathy; anterior horn cell; methotrexate; neurological complication.

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Child
Humans
Methotrexate / therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Spinal Cord Diseases*

Substances

Methotrexate

Grants and funding

NFRCH20-0011/Japanese Red Cross Nagoya 1st. Hospital Research Grant